This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Tamer Ahmed: Innovating Cancer Treatment Solutions
Introduction
Tamer Ahmed, a dedicated inventor based in Edison, NJ, is making significant contributions to the field of cancer treatment. With a focus on innovative approaches to combat CDK4/6-mediated cancers, Ahmed is paving the way for new therapeutic methods that could improve patient outcomes.
Latest Patents
Ahmed holds a patent for "Compositions and methods for treating CDK4/6-mediated cancer." This patent outlines methods for designing heterobifunctional small molecules that selectively degrade and disrupt CDK4/6. These innovative compounds aim to provide effective treatment options for patients suffering from cancers driven by the CDK4/6 pathway.
Career Highlights
Tamer Ahmed is currently affiliated with the Icahn School of Medicine at Mount Sinai. His role at this prestigious research institution allows him to collaborate with leading scientists and contribute to groundbreaking cancer research. The focus on translational medicine in his work underscores his commitment to transforming scientific discoveries into real-world applications.
Collaborations
Throughout his career, Ahmed has partnered with esteemed colleagues such as Jian Jin and Xiaobao Yang. These partnerships enhance the development and refinement of innovative treatments, demonstrating the power of collaboration in scientific research and invention.
Conclusion
Tamer Ahmed is a remarkable inventor whose work in the realm of cancer treatment holds great promise. Through his innovative patent and collaborative efforts at the Icahn School of Medicine at Mount Sinai, he is contributing to the fight against cancer and providing hope for patients around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
